Your browser doesn't support javascript.
loading
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT).
Mohty, M; Malard, F; Abecassis, M; Aerts, E; Alaskar, A S; Aljurf, M; Arat, M; Bader, P; Baron, F; Bazarbachi, A; Blaise, D; Ciceri, F; Corbacioglu, S; Dalle, J-H; Duarte, R F; Fukuda, T; Huynh, A; Masszi, T; Michallet, M; Nagler, A; NiChonghaile, M; Pagluica, T; Peters, C; Petersen, F B; Richardson, P G; Ruutu, T; Savani, B N; Wallhult, E; Yakoub-Agha, I; Carreras, E.
Afiliação
  • Mohty M; Hematology department, Hôpital Saint-Antoine, and Université Pierre & Marie Curie, Paris, France.
  • Malard F; Hematology department, Hôpital Saint-Antoine, and Université Pierre & Marie Curie, Paris, France.
  • Abecassis M; Inst Portugues Oncologia, Lisboa, Portugal.
  • Aerts E; Department of Haematology, University Hospital Zurich, Zurich, Switzerland.
  • Alaskar AS; King Abdullah International Medical Research Center/King Saud Bin Abdulaziz University for Health Sciences, Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Aljurf M; King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Arat M; Sisli Florence Nightingale Hospital, HSCT Unit, Istanbul, Turkey.
  • Bader P; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University, Frankfurt/Main, Germany.
  • Baron F; Department of Hematology, University of Liege, Liege, Belgium.
  • Bazarbachi A; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
  • Blaise D; Blood and Marrow Transplantation Program, Hematology Department, Institut Paoli-Calmettes, Marseille, France.
  • Ciceri F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Corbacioglu S; Department of Hematology, Oncology, and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany.
  • Dalle JH; Department of Hematology and Immunology, Hospital Robert Debre, Paris 7-Paris Diderot University, Paris, France.
  • Duarte RF; Department of Haematology, Institut Català d'Oncología (ICO) - Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain.
  • Fukuda T; HSCT division, National Cancer Center Hospital, Tokyo, Japan.
  • Huynh A; Hematology department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France.
  • Masszi T; Department of Hematology and Stem Cell Transplantation, St. Istvan and St. Laszlo Hospital, Budapest 3 Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Michallet M; Hematology Department, Groupement Hospitalier Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon EST, Pierre Bénite, France.
  • Nagler A; Hematology and Bone Marrow Transplantation, Chaim Sheba Medical center, Tel-Hashomer, Israel.
  • NiChonghaile M; National Stem Cell Transplant Unit (Adults), Department of Haematology, St James's Hospital and Academic Department of Haematology, Trinity College Dublin, Dublin, Ireland.
  • Pagluica T; Department of Haematology, King's College Hospital, London, UK.
  • Peters C; Department of Pediatrics, St. Anna Kinderspital, Vienna, Austria.
  • Petersen FB; LDS Hospital, Salt Lake City, UT, USA.
  • Richardson PG; Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ruutu T; Comprehensive Cancer Center, Helsinki University Central Hospital, Helsinki, Finland.
  • Savani BN; Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, TN, USA.
  • Wallhult E; Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Yakoub-Agha I; Bone Marrow Transplantation Unit, CHU de Lille, Lille, France.
  • Carreras E; 1] Josep Carreras Leukaemia Research Institute, Barcelona, Spain [2] Haematology Department, Hospital Clinic, Barcelona, Spain [3] Spanish Bone Marrow Donor Program, Josep Carreras Foundation, Barcelona, Spain.
Bone Marrow Transplant ; 50(6): 781-9, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25798682
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Doenças Vasculares / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Doenças Vasculares / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article